Pharmacogenomic studies of hypertension: paving the way for personalized antihypertensive treatment
Author:
Affiliation:
1. Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
2. Division of Nephrology, University of Chicago, Chicago, IL, USA
Funder
NIH/NIDDK
NIH/NIGMS
Publisher
Informa UK Limited
Subject
Drug Discovery,Pharmacology,Genetics,Molecular Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/23808993.2018.1420419
Reference97 articles.
1. Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice
2. Adoption of a clinical pharmacogenomics implementation program during outpatient care-initial results of the University of Chicago “1,200 Patients Project”
3. Implementation of a pharmacogenomics consult service to support the INGENIOUS trial
4. Development and implementation of a pharmacist-managed clinical pharmacogenetics service
5. The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antihypertensives associated adverse events: a review of mechanisms and pharmacogenomic biomarkers available evidence in multi-ethnic populations;Frontiers in Pharmacology;2023-12-01
2. Evaluating Drug Effectiveness for Antihypertensives in Heart Failure Prognosis: Leveraging Composite Clinical Endpoints and Biomarkers from Electronic Health Records;Proceedings of the 14th ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics;2023-09-03
3. Personalized antihypertensive treatment guided by pharmacogenomics in China;Cardiovascular Diagnosis and Therapy;2022-10
4. Pharmacogenomics of Antihypertensive Drugs in Brazil: recent progress and clinical implications;Endocrine, Metabolic & Immune Disorders - Drug Targets;2021-12-22
5. Pharmacogenomics of hypertension in chronic kidney disease: the CKD-PGX study;Kidney360;2021-12-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3